Stock listing
Claritas Pharmaceuticals Inc.
Selected listing: CLAZF · OTC · USD · US
Claritas Pharmaceuticals Inc. (OTC:CLAZF), Health Technology. Latest release Apr 7, 2022: Claritas Announces Approval from OTC to Up-List to OTCQB.
- Ticker
- OTC:CLAZF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Claritas Pharmaceuticals Inc.
Claritas Pharmaceuticals Inc. is a public company traded under the ticker CLAZF in the American market. The company focuses on developing innovative therapeutic solutions. Claritas aims to address unmet medical needs through its research and development efforts.
Latest news from Claritas Pharmaceuticals Inc.
Claritas Announces Approval from OTC to Up-List to OTCQB
April 7, 2022
Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107
April 5, 2022
BCSC-OSC Revocation of Cease Trade Order
January 21, 2021
BCSC-OSC Partial Revocation of Cease Trade Order
July 13, 2020
BCSC Cease Trade Order
June 21, 2020
Research Claritas Pharmaceuticals Inc.
Claritas Pharmaceuticals Inc. company profile
View the public company page for Claritas Pharmaceuticals Inc. on 6ix.
Claritas Pharmaceuticals Inc. news
Read company news and market updates connected to Claritas Pharmaceuticals Inc..
Claritas Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Claritas Pharmaceuticals Inc..